Here Is My Question:
What is the status of anti-lingo, and will it be available as an FDA approved drug for MS by 2018?
Two Phase II trials of anti-Lingo are currently enrolling patients; the results of these studies will determine if phase III trials are warranted. Since this is a therapy being developed for a new indication it is unlikely that it will be available by 2018.
Rip Kinkel, MD
PLEASE NOTE: The information/opinions on this site should be used as an information resource only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.